Diana Hausman
2021 - Zymeworks
In 2021, Diana Hausman earned a total compensation of $1.6M as Former Chief Medical Officer at Zymeworks, a 15% decrease compared to previous year.
Compensation breakdown
| Option Awards | $1,178,164 |
|---|---|
| Salary | $173,792 |
| Stock Awards | $282,913 |
| Other | $11,220 |
| Total | $1,646,089 |
Hausman received $1.2M in option awards, accounting for 72% of the total pay in 2021.
Hausman also received $173.8K in salary, $282.9K in stock awards and $11.2K in other compensation.
Rankings
In 2021, Diana Hausman's compensation ranked 6,849th out of 12,415 executives tracked by ExecPay. In other words, Hausman earned more than 44.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,849 out of 12,415 | 45th |
Division Manufacturing | 2,984 out of 5,505 | 46th |
Major group Chemicals And Allied Products | 1,323 out of 2,375 | 44th |
Industry group Drugs | 1,179 out of 2,096 | 44th |
Industry Pharmaceutical Preparations | 859 out of 1,546 | 44th |
Source: SEC filing on November 25, 2022.
Hausman's colleagues
We found five more compensation records of executives who worked with Diana Hausman at Zymeworks in 2021.